FDA Inspection 1313212 — Wesley Pharmaceuticals
The FDA completed an inspection of Wesley Pharmaceuticals on March 16, 2026 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Orlando, FL (United States)